An early predictor of the outcome of patients with ventilator-associated pneumonia

Chang Gung Medical Journal

Volumn 33, Issue 3, 2010, Pages 274-282

  Huang, Kuo Tung ^a   Tseng, Chia Cheng ^a   Fang, Wen Feng ^a   Lin, Meng Chih ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Acute physiological assessment and chronic health evaluation (APACHE) II score; Clinical pulmonary infection score (CPIS); Ventilator associated pneumonia (VAP)

Indexed keywords

ADULT; AGED; ANTIBIOTIC THERAPY; APACHE; BACTEREMIA; BACTERIUM CULTURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL PULMONARY INFECTION SCORE; COLLAGEN VASCULAR DISEASE; COMORBIDITY; COMPARATIVE STUDY; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; HOSPITAL ADMISSION; HOSPITAL INFECTION; HUMAN; HYPERTENSION; INTENSIVE CARE UNIT; KIDNEY FAILURE; LOWER RESPIRATORY TRACT INFECTION; MALE; MORTALITY; MULTIDRUG RESISTANCE; PREDICTION; PROGNOSIS; RESPIRATORY TRACT INTUBATION; RETROSPECTIVE STUDY; REVIEW; RISK FACTOR; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; VASCULAR DISEASE; VENTILATOR ASSOCIATED PNEUMONIA; MIDDLE AGED; MULTIVARIATE ANALYSIS; PNEUMONIA, VENTILATOR-ASSOCIATED;

ANTIINFECTIVE AGENT;

AGED; ANTI-BACTERIAL AGENTS; APACHE; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PNEUMONIA, VENTILATOR-ASSOCIATED; RETROSPECTIVE STUDIES;

EID: 77954506028     PISSN: 20720939     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Safdar N, Dezfulian C, Collard HR, Saint S. Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med 2005;33:2184-93.
2. Luna CM, Blanzaco D, Niederman MS, Matarucco W, Baredes NC, Desmery P, Palizas F, Menga G, Rios F, Apezteguia C. Resolution of ventilator-associated pneumonia: prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome. Crit Care Med 2003;31:676-82.
3. Póvoa P, Coelho L, Almeida E, Fernandes A, Mealha R, Moreira P, Sabino H. C-reactive protein as a marker of ventilator-associated pneumonia resolution: a pilot study. Eur Respir J 2005;25:804-12.
4. Luyt CE, Guérin V, Combes A, Trouillet JL, Ayed SB, Bernard M, Gibert C, Chastre J. Procalcitonin kinetics as a prognostic marker of ventilator-associated pneumonia. Am J Respir Crit Care Med 2005;171:48-53.
5. Seligman R, Meisner M, Lisboa TC, Hertz FT, Filippin TB, Fachel JM, Teixeira PJ. Decreases in procalcitonin and C-reactive protein are strong predictors of survival in ventilator-associated pneumonia. Crit Care 2006;10:R125.
6. Ranes JL, Gordon SM, Chen P, Fatica C, Hammel J, Gonzales JP, Arroliga AC. Predictors of long-term mortality in patients with ventilator-associated pneumonia. Am J Med 2006;119:897.e13-9.
7. Combes A, Luyt CE, Fagon JY, Wolff M, Trouillet JL, Chastre J. Early predictors for infection recurrence and death in patients with ventilator-associated pneumonia. Crit Care Med 2007;35:146-54.
8. Pugin J, Auckenthaler R, Mili N, Janssens JP, Lew PD, Suter PM. Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic blind bronchoalveolar lavage fluid. Am Rev Respir Dis 1991;143:1121-9.
9. Fartoukh M, Maitre B, Honoré S, Cerf C, Zahar JR, Brun-Buisson C. Diagnosing pneumonia during mechanical ventilation: The clinical pulmonary infection score revisited. Am J Respir Crit Care Med 2003;168:173-9.
10. Guidelines for the Management of adults with hospital- acquired, ventilator-associated, and healthcare-associated Pneumonia. Am J Respir Crit Care Med 2005;171:388-416.
11. Michel F, Franceschini B, Berger P, Arnal JM, Gainnier M, Sainty JM, Papazian L. Early antibiotic treatment for BAL-confirmed ventilator-associated pneumonia: a role for routine endotracheal aspirate cultures. Chest 2005;127:589-97.
12. Lee SC, Hua CC, Yu TJ, Shieh WB, See LC. Risk factors of mortality for nosocomial pneumonia: importance of initial anti-microbial therapy. Int J Clin Pract 2005;59:39-45.
13. Kollef MH, Morrow LE, Niederman MS, Leeper KV, Anzueto A, Benz-Scott L, Rodino FJ. Clinical characteristics and treatment patterns among patients with ventilator- associated pneumonia. Chest 2006;129:1210-8.
14. Taylor GD, Buchanan-Chell M, Kirkland T, McKenzie M, Wiens R. Bacteremic nosocomial pneumonia. A 7-year experience in one institution. Chest 1995;108:786-8.
15. Bryan CS, Reynolds KL. Bacteremic nosocomial pneumonia. Analysis of 172 episodes from a single metropolitan area. Am Rev Respir Dis 1984;129:668-71.
16. Agbaht K, Diaz E, Muñoz E, Lisboa T, Gomez F, Depuydt PO, Blot SI, Rello J. Bacteremia in patients with ventilator-associated pneumonia is associated with increased mortality: A study comparing bacteremic vs. nonbacteremic ventilator-associated pneumonia. Crit Care Med 2007;35:2064-70.
17. Gursel G, Demirtas S. Value of APACHE II, SOFA and CPIS scores in predicting prognosis in patients with ventilator-associated pneumonia. Respiration 2006;73:503-8.
18. Gursel G, Aydogdu M, Ozyilmaz E, Ozis TN. Risk factors for treatment failure in patients with ventilator-associated pneumonia receiving appropriate antibiotic therapy. J Crit Care 2008;23:34-40.